Uncommon Side Effects of Sunitinib Therapy in a Patient with Metastatic Renal Cell Cancer: Case Report
Sunitinib is an orally administered multikinase inhibitor. This therapy can provoke uncommon side effects such as pancytopenia, tumor lysis syndrome, cardiac disorders, thromboembolic incidents, intestinal perforation, pancreatitis, acute renal failure, etc. We report a case of a 63-year-old female...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Sestre Milosrdnice University hospital, Institute of Clinical Medical Research
2018-01-01
|
| Серія: | Acta Clinica Croatica |
| Предмети: | |
| Онлайн доступ: | https://hrcak.srce.hr/file/315460 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|